CHEBI:82677 - ridaforolimus

ChEBI IDCHEBI:82677
ChEBI Nameridaforolimus
Stars
DefinitionA semisynthetic derivative that is sirolimus in which the hydroxy group attached to the cyclohexyl moiety has been converted to the corresponding dimethylphosphinate.
Last Modified3 December 2019
SubmitterGareth Owen
DownloadsMolfile
FormulaC53H84NO14P
Net Charge0
Average Mass990.222
Monoisotopic Mass989.56294
SMILES[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)/C=C(\C)[C@@H](O)C(OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)[C@@H](OC)C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)CC[C@@H](OP(C)(C)=O)[C@H](OC)C1
InChIInChI=1S/C53H84NO14P/c1-32-18-14-13-15-19-33(2)44(63-8)30-40-23-21-38(7)53(61,67-40)50(58)51(59)54-25-17-16-20-41(54)52(60)66-45(35(4)28-39-22-24-43(46(29-39)64-9)68-69(11,12)62)31-42(55)34(3)27-37(6)48(57)49(65-10)47(56)36(5)26-32/h13-15,18-19,27,32,34-36,38-41,43-46,48-49,57,61H,16-17,20-26,28-31H2,1-12H3/b15-13+,18-14+,33-19+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49?,53-/m1/s1
InChIKeyBUROJSBIWGDYCN-QSRQGROMSA-N
Wikipedia
Roles Classification
Biological Role:
mTOR inhibitor  A protein kinase inhibitor of the mammalian target of rapamycin (mTOR), a protein that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis and transcription. mTOR inhibitors are used to prevent transplant rejection and in treatment of cancer.
Application:
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
ChEBI Ontology
Outgoing Relation(s)
ridaforolimus (CHEBI:82677) has functional parent sirolimus (CHEBI:9168)
ridaforolimus (CHEBI:82677) has role antineoplastic agent (CHEBI:35610)
ridaforolimus (CHEBI:82677) has role mTOR inhibitor (CHEBI:68481)
ridaforolimus (CHEBI:82677) is a cyclic acetal (CHEBI:59770)
ridaforolimus (CHEBI:82677) is a macrolide lactam (CHEBI:145565)
ridaforolimus (CHEBI:82677) is a phosphinic ester (CHEBI:26043)
ridaforolimus (CHEBI:82677) is a semisynthetic derivative (CHEBI:72588)
IUPAC Name 
(1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl dimethylphosphinate
INNs  Source
ridaforolimusWHO MedNet
ridaforolimusWHO MedNet
ridaforolimusumWHO MedNet
ridaforolimusWHO MedNet
Synonyms  Source
AP 23573KEGG COMPOUND
deforolimusKEGG COMPOUND
MK 8669ChemIDplus
MK-8669ChemIDplus
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-((1R)-2-((1S,3R,4R)-4-((dimethylphosphinoyl)oxy)-3-methoxycyclohexyl)-1-methylethyl)-1,18- dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4- azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene- 2,3,10,14,20-pentoneChemIDplus
AP23573ChemIDplus
Manual XrefsDatabases
RidaforolimusWikipedia
D08900KEGG DRUG
C15183KEGG COMPOUND
Registry NumbersSources
Reaxys:11886334Reaxys
CAS:572924-54-0ChemIDplus
Citations